Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands

1.

A.C. Gore, V.A. Chappell, S.E. Fenton, J.A. Flaws, A. Nadal, G.S. Prins, J. Toppari, R.T. Zoeller, EDC-2: the endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 36, E1–E150 (2015). https://doi.org/10.1210/er.2015-1010CrossRefPubMedPubMedCentral

2.

E.R. Kabir, M.S. Rahman, I. Rahman, A review on endocrine disruptors and their possible impacts on human health. Environ. Toxicol. Pharmacol. 40, 241–258 (2015). https://doi.org/10.1016/j.etap.2015.06.009CrossRefPubMed

3.

P. Balaguer, V. Delfosse, M. Grimaldi, W. Bourguet, Structural and functional evidences for the interactions between nuclear hormone receptors and endocrine disruptors at low doses. Comptes Rendus Biologies 340, 414–420 (2017). https://doi.org/10.1016/j.crvi.2017.08.002CrossRefPubMed

4.

J.J. Heindel, R. Newbold, T.T. Schug, Endocrine disruptors and obesity. Nat. Rev. Endocrinol. 11, 653–661 (2015). https://doi.org/10.1038/nrendo.2015.163CrossRefPubMed

5.

R.M. Sargis, Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals. Endocr. Disruptors 3, e1080788 (2015). https://doi.org/10.1080/23273747.2015.1080788CrossRef

6.

W. Mnif, A.I.H. Hassine, A. Bouaziz, A. Bartegi, O. Thomas, B. Roig, Effect of endocrine disruptor pesticides: a review. Int. J. Environ. Res. Public. Health 8, 2265–2303 (2011). https://doi.org/10.3390/ijerph8062265CrossRefPubMedPubMedCentral

7.

G.J. Nohynek, C.J. Borgert, D. Dietrich, K.K. Rozman, Endocrine disruption: Fact or urban legend? Toxicol. Lett. 223, 295–305 (2013). https://doi.org/10.1016/j.toxlet.2013.10.022CrossRefPubMed

8.

R. Kiyama, Y. Wada-Kiyama, Estrogenic endocrine disruptors: Molecular mechanisms of action. Environ. Int. 83, 11–40 (2015). https://doi.org/10.1016/j.envint.2015.05.012CrossRefPubMed

9.

K. Moriyama, T. Tagami, T. Usui, M. Naruse, T. Nambu, Y. Hataya, N. Kanamoto, Y. Li, A. Yasoda, H. Arai, K. Nakao, Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription. J. Clin. Endocrinol. Metab. 92, 1066–1072 (2007). https://doi.org/10.1210/jc.2006-1621CrossRefPubMed

10.

S.de Coster, N.van Larebeke,, Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J. Environ. Public Health 2012, 1–52 (2012). https://doi.org/10.1155/2012/713696CrossRef

11.

T.T. Schug, A. Janesick, B. Blumberg, J.J. Heindel, Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 127, 204–215 (2011). https://doi.org/10.1016/j.jsbmb.2011.08.007CrossRefPubMedPubMedCentral

12.

A.M. Zama, M. Uzumcu, Epigenetic effects of endocrine-disrupting chemicals on female reproduction: An ovarian perspective. Front. Neuroendocrinol. 31, 420–439 (2010). https://doi.org/10.1016/j.yfrne.2010.06.003CrossRefPubMedPubMedCentral

13.

C. Monneret, What is an endocrine disruptor? Comptes Rendus Biologies 340, 403–405 (2017). https://doi.org/10.1016/j.crvi.2017.07.004CrossRefPubMed

14.

F. Baldi, A. Mantovani, A new database for food safety: EDID (endocrine disrupting chemicals–diet interaction database). Reprod. Toxicol. 26, 57 (2008). https://doi.org/10.1016/j.reprotox.2008.05.005CrossRef

15.

K. Svensson, E. Tanner, C. Gennings, C. Lindh, H. Kiviranta, S. Wikström, C.-G. Bornehag, Prenatal exposures to mixtures of endocrine disrupting chemicals and children’s weight trajectory up to age 5.5 in the SELMA study. Sci. Rep. 11, 11036 (2021). https://doi.org/10.1038/s41598-021-89846-5CrossRefPubMedPubMedCentral

16.

Agency for Toxic Substances and Disease Registry. Available at https://www.atsdr.cdc.gov/. [Accessed April 10, 2022].

17.

A. Gore, Neuroendocrine targets of endocrine disruptors. HORMONES 9, 16–27 (2010). https://doi.org/10.14310/horm.2002.1249CrossRefPubMed

18.

A.C. Pesatori, D. Consonni, M. Rubagotti, P. Grillo, P.A. Bertazzi, Cancer incidence in the population exposed to dioxin after the “Seveso accident”: twenty years of follow-up. Environ. Health 8, 39 (2009). https://doi.org/10.1186/1476-069X-8-39CrossRefPubMedPubMedCentral

19.

S. Cannavò, F. Ferraù, M. Ragonese, L. Curtò, M.L. Torre, M. Magistri, A. Marchese, A. Alibrandi, F. Trimarchi, Increased prevalence of acromegaly in a highly polluted area. Eur. J. Endocrinol. 163, 509–513 (2010). https://doi.org/10.1530/EJE-10-0465CrossRefPubMed

20.

L. Tapella, A. Sesta, M.F. Cassarino, V. Zunino, M.G. Catalano, F.P. Giraldi, Benzene and 2-ethyl-phthalate induce proliferation in normal rat pituitary cells. Pituitary 20, 311–318 (2017). https://doi.org/10.1007/S11102-016-0777-3CrossRefPubMed

21.

S. Cannavo, F. Trimarchi, F. Ferraù, Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden. Mol. Cell. Endocrinol. 457, 81–88 (2017). https://doi.org/10.1016/j.mce.2016.12.019CrossRefPubMed

22.

C. Lloyd, A. Grossman, The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas. Endocrine 46, 387–396 (2014). https://doi.org/10.1007/s12020-013-0125-6CrossRefPubMed

23.

go back to reference L.C. Hernández-Ramírez, P. Gabrovska, J. Dénes, K. Stals, G. Trivellin, D. Tilley, F. Ferraù, J. Evanson, S. Ellard, A.B. Grossman, F. Roncaroli, M.R. Gadelha, M. Korbonits, A. Agha, S.A. Akker, E.D. Aflorei, S. Alföldi, W. Arlt, B. Atkinson, A. Aulinas-Masó, S.J. Aylwin, P.F. Backeljauw, C. Badiu, S. Baldeweg, G. Bano, A. Barkan, J. Barwell, C. Bernal-González, G.M. Besser, J.S. Bevan, J. Blair, P. Bouloux, L. Bradley, M. Buchfelder, M. Cakir, N. Canham, P. Carroll, H.S. Chahal, T. Cheetham, F. Chentli, R.N. Clayton, M. Cohen, T. Cole, H. Courtney, E. Crowne, D. Cuthbertson, J. Dal, N. Dalantaeva, C. Daousi, K. Darzy, M. Dattani, J.H. Davies, J. Davis, M. de Castro, L. de Marinis, W. Drake, P. Dutta, L. Dzeranova, B. Edén-Engström, R. Eeles, M. Elfving, M. Elston, L. Emmerson, N. Fersht, S. Fica, S. Fischli, D. Flanagan, M. Fleseriu, P.U. Freda, T. Friedman, L.A. Frohman, P. Gallego, E. Gevers, E. Gláz, J.A. Goldman, A.P. Goldstone, M. Goth, L. Greenhalgh, J. Grieve, M. Guitelman, A. Gürlek, M. Gurnell, K. Horvath, T.A. Howlett, C. Höybye, S. Hunter, D. Iacovazzo, P. Igaz, W.J. Inder, T. Iwata, L. Izatt, S. Jagadeesh, G. Kaltsas, F. Kaplan, N. Karavitaki, D. Kastelan, M. Katz, T. Kearney, B. Khoo, C. Kiraly-Borri, R. Knispelis, G.L. Kovács, A.V. Kumar, E.R. Laws, R.M. Lechan, M.J. Levy, K. Lewandowski, J. Lo, N. Maartens, A. Matsuno, B. McGowan, S.E. McQuaid, M. Medic-Stojanoska, M. Mercado-Atri, E. Mezősi, D. Miljic, K.K. Miller, S. Modenesi, M.E. Molitch, J. Monson, D.G. Morris, P.J. Morrison, A. Munir, R.D. Murray, M. Musat, N. Musolino, L. Nachtigall, J. Newell-Price, A. Ogilvie, S.M. Orme, I. Paşcanu, A. Patócs, C. Patterson, S.H. Pearce, F. Pecori Giraldi, M. Pfeifer, V. Popovic, N. Poplawski, M. Powell, P. Pullan, R. Quinton, S. Radian, H. Randeva, A. Ribeiro-Oliveira, C. Rodd, F. Ryan, R. Salvatori, C. Schöfl, D. Shears, K. Shotliff, B.S. Soares, N. Somasundaram, A. Spada, J. Sperber, H.A. Spoudeas, S. Stewart, H. Storr, C. Strasburger, M.E. Street, F. Swords, R.V. Thakker, E. Tham, C. Thompson, D.M.O. Thorner, M. Tóth, P.J. Trainer, S. Tsagarakis, M. Tzanela, J. Vadász, V. Vaks, R. Verkauskiene, J.A. Wass, S.M. Webb, A. Weber, S. Yamada, S. Yarman, P. Yeoh, K. Yoshimoto, N.N. Zammitt, Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. J. Clin. Endocrinol. Metab. 100, e1242–e1254 (2015). https://doi.org/10.1210/jc.2015-1869CrossRefPubMedPubMedCentral L.C. Hernández-Ramírez, P. Gabrovska, J. Dénes, K. Stals, G. Trivellin, D. Tilley, F. Ferraù, J. Evanson, S. Ellard, A.B. Grossman, F. Roncaroli, M.R. Gadelha, M. Korbonits, A. Agha, S.A. Akker, E.D. Aflorei, S. Alföldi, W. Arlt, B. Atkinson, A. Aulinas-Masó, S.J. Aylwin, P.F. Backeljauw, C. Badiu, S. Baldeweg, G. Bano, A. Barkan, J. Barwell, C. Bernal-González, G.M. Besser, J.S. Bevan, J. Blair, P. Bouloux, L. Bradley, M. Buchfelder, M. Cakir, N. Canham, P. Carroll, H.S. Chahal, T. Cheetham, F. Chentli, R.N. Clayton, M. Cohen, T. Cole, H. Courtney, E. Crowne, D. Cuthbertson, J. Dal, N. Dalantaeva, C. Daousi, K. Darzy, M. Dattani, J.H. Davies, J. Davis, M. de Castro, L. de Marinis, W. Drake, P. Dutta, L. Dzeranova, B. Edén-Engström, R. Eeles, M. Elfving, M. Elston, L. Emmerson, N. Fersht, S. Fica, S. Fischli, D. Flanagan, M. Fleseriu, P.U. Freda, T. Friedman, L.A. Frohman, P. Gallego, E. Gevers, E. Gláz, J.A. Goldman, A.P. Goldstone, M. Goth, L. Greenhalgh, J. Grieve, M. Guitelman, A. Gürlek, M. Gurnell, K. Horvath, T.A. Howlett, C. Höybye, S. Hunter, D. Iacovazzo, P. Igaz, W.J. Inder, T. Iwata, L. Izatt, S. Jagadeesh, G. Kaltsas, F. Kaplan, N. Karavitaki, D. Kastelan, M. Katz, T. Kearney, B. Khoo, C. Kiraly-Borri, R. Knispelis, G.L. Kovács, A.V. Kumar, E.R. Laws, R.M. Lechan, M.J. Levy, K. Lewandowski, J. Lo, N. Maartens, A. Matsuno, B. McGowan, S.E. McQuaid, M. Medic-Stojanoska, M. Mercado-Atri, E. Mezősi, D. Miljic, K.K. Miller, S. Modenesi, M.E. Molitch, J. Monson, D.G. Morris, P.J. Morrison, A. Munir, R.D. Murray, M. Musat, N. Musolino, L. Nachtigall, J. Newell-Price, A. Ogilvie, S.M. Orme, I. Paşcanu, A. Patócs, C. Patterson, S.H. Pearce, F. Pecori Giraldi, M. Pfeifer, V. Popovic, N. Poplawski, M. Powell, P. Pullan, R. Quinton, S. Radian, H. Randeva, A. Ribeiro-Oliveira, C. Rodd, F. Ryan, R. Salvatori, C. Schöfl, D. Shears, K. Shotliff, B.S. Soares, N. Somasundaram, A. Spada, J. Sperber, H.A. Spoudeas, S. Stewart, H. Storr, C. Strasburger, M.E. Street, F. Swords, R.V. Thakker, E. Tham, C. Thompson, D.M.O. Thorner, M. Tóth, P.J. Trainer, S. Tsagarakis, M. Tzanela, J. Vadász, V. Vaks, R. Verkauskiene, J.A. Wass, S.M. Webb, A. Weber, S. Yamada, S. Yarman, P. Yeoh, K. Yoshimoto, N.N. Zammitt, Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. J. Clin. Endocrinol. Metab. 100, e1242–e1254 (2015). https://doi.org/10.1210/jc.2015-1869CrossRefPubMedPubMedCentral

24.

V.H. Dang, T.H. Nguyen, G.S. Lee, K.C. Choi, E.B. Jeung, In vitro exposure to xenoestrogens induces growth hormone transcription and release via estrogen receptor-dependent pathways in rat pituitary GH3 cells. Steroids 74, 707–714 (2009). https://doi.org/10.1016/j.steroids.2009.03.002CrossRefPubMed

25.

N. Fortunati, F. Guaraldi, V. Zunino, F. Penner, V. D’Angelo, F. Zenga, F.P. Giraldi, M.G. Catalano, E. Arvat, Effects of environmental pollutants on signaling pathways in rat pituitary GH3 adenoma cells. Environ. Res. 158, 660–668 (2017). https://doi.org/10.1016/j.envres.2017.07.015CrossRefPubMed

26.

J. Simard, J.-F. Hubert, T. Hosseinzadeh, F. Labrie, Stimulation of growth hormone release and synthesis by estrogens in rat anterior pituitary cells in culture. Endocrinology 119, 2004–2011 (1986). https://doi.org/10.1210/endo-119-5-2004CrossRefPubMed

27.

Y. Iwasaki, M. Morishita, M. Asai, A. Onishi, M. Yoshida, Y. Oiso, K. Inoue, Effects of hormones targeting nuclear receptors on transcriptional regulation of the growth hormone gene in the MtT/S rat somatotrope cell line. Neuroendocrinology 79, 229–236 (2004). https://doi.org/10.1159/000078787CrossRefPubMed

28.

R. Steinmetz, N.G. Brown, D.L. Allen, R.M. Bigsby, N. Ben-Jonathan, The environmental estrogen bisphenol a stimulates prolactin release in vitro and in vivo*. Endocrinology 138, 1780–1786 (1997). https://doi.org/10.1210/endo.138.5.5132CrossRefPubMed

29.

T.-Y. Chun, J. Gorski, High concentrations of bisphenol a induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line. Toxicol. Appl. Pharmacol. 162, 161–165 (2000). https://doi.org/10.1006/taap.1999.8840CrossRefPubMed

30.

J. Rousseau, L. Cossette, S. Grenier, M.G. Martinoli, Modulation of prolactin expression by xenoestrogens. Gen. Comp. Endocrinol. 126, 175–182 (2002). https://doi.org/10.1006/gcen.2002.7789CrossRefPubMed

31.

K. Jurkowska, E.M. Kratz, E. Sawicka, A. Piwowar, The impact of metalloestrogens on the physiology of male reproductive health as a current problem of the XXI century. J. Physiol. Pharmacol. 70, 337–355 (2019). https://doi.org/10.26402/jpp.2019.3.02CrossRef

32.

R. Lucchini, E. Albini, I. Cortesi, D. Placidi, E. Bergamaschi, F. Traversa, L. Alessio, Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology 21, 805–811 (2000)PubMed

33.

S. Govoni, F. Battaini, C. Fernicola, L. Castelletti, M. Trabucchi, Plasma prolactin concentrations in lead exposed workers. J. Environ. Pathol. Toxicol. Oncol. 7, 13–15 (n.d.).

34.

J.D. Meeker, M.G. Rossano, B. Protas, M.P. Diamond, E. Puscheck, D. Daly, N. Paneth, J.J. Wirth, Multiple metals predict prolactin and thyrotropin (TSH) levels in men. Environ. Res. 109, 869–873 (2009). https://doi.org/10.1016/j.envres.2009.06.004CrossRefPubMedPubMedCentral

35.

S. Telišman, B. Čolak, A. Pizent, J. Jurasović, P. Cvitković, Reproductive toxicity of low-level lead exposure in men. Environ. Res. 105, 256–266 (2007). https://doi.org/10.1016/j.envres.2007.05.011CrossRefPubMed

36.

C. de Burbure, J.-P. Buchet, A. Leroyer, C. Nisse, J.-M. Haguenoer, A. Mutti, Z. Smerhovský, M. Cikrt, M. Trzcinka-Ochocka, G. Razniewska, M. Jakubowski, A. Bernard, Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ. Health Perspect. 114, 584–590 (2006). https://doi.org/10.1289/ehp.8202CrossRefPubMed

37.

L. Takser, D. Mergler, J. Lafond, Very low level environmental exposure to lead and prolactin levels during pregnancy. Neurotoxicology Teratol. 27, 505–508 (2005). https://doi.org/10.1016/j.ntt.2005.03.009CrossRef

38.

A. Laisi, R. Tuominen, P. Männistö, K. Savolainen, J. Mattila, The Effect of Maneb, Zineb, and Ethylenethiourea on the Humoral Activity of the Pituitary-Thyroid Axis in Rat. in (1985), pp. 253–258.

39.

S.P. Pandey, B. Mohanty, The neonicotinoid pesticide imidacloprid and the dithiocarbamate fungicide mancozeb disrupt the pituitary–thyroid axis of a wildlife bird. Chemosphere 122, 227–234 (2015). https://doi.org/10.1016/J.CHEMOSPHERE.2014.11.061CrossRefPubMed

40.

H.J. Sun, H.B. Li, P. Xiang, X. Zhang, L.Q. Ma, Short-term exposure of arsenite disrupted thyroid endocrine system and altered gene transcription in the HPT axis in zebrafish. Environ. Pollut. 205, 145–152 (2015). https://doi.org/10.1016/J.ENVPOL.2015.05.037CrossRefPubMed

41.

S. Sharan, K. Nikhil, P. Roy, Disruption of thyroid hormone functions by low dose exposure of tributyltin: An in vitro and in vivo approach. Gen. Comp. Endocrinol. 206, 155–165 (2014). https://doi.org/10.1016/J.YGCEN.2014.07.027CrossRefPubMed

42.

A.P. Santos-Silva, M.N. Andrade, P. Pereira-Rodrigues, F.D. Paiva-Melo, P. Soares, J.B. Graceli, G.R.M. Dias, A.C.F. Ferreira, D.P. de Carvalho, L. Miranda-Alves, Frontiers in endocrine disruption: Impacts of organotin on the hypothalamus-pituitary-thyroid axis. Mol. Cell. Endocrinol. 460, 246–257 (2018). https://doi.org/10.1016/J.MCE.2017.07.038CrossRefPubMed

43.

M.V. Rosati, L. Montuori, T. Caciari, C. Sacco, M. Marrocco, G. Tomei, B. Scala, A. Sancini, V. Anzelmo, S. Bonomi, F. Tomei, Correlation between urinary cadmium and thyroid hormones in outdoor workers exposed to urban stressors. Toxicol. Ind. Health 32, 1978–1986 (2016). https://doi.org/10.1177/0748233715602833CrossRefPubMed

44.

V. Ballesteros, O. Costa, C. Iñiguez, T. Fletcher, F. Ballester, M.J. Lopez-Espinosa, Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies. Environ. Int. 99, 15–28 (2017). https://doi.org/10.1016/J.ENVINT.2016.10.015CrossRefPubMed

45.

C. Koopman-Esseboom, D.C. Morse, N. Weisglas-Kuperus, I.J. Lutkeschipholt, C.G. van der Paauw, L.G.M.T. Tuinstra, A. Brouwer, P.J.J. Sauer, Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants. Pediatr. Res. 36, 468–473 (1994). https://doi.org/10.1203/00006450-199410000-00009CrossRefPubMed

46.

L. Hagmar, Polychlorinated biphenyls and thyroid status in humans: a review. Thyroid 13, 1021–1028 (2003). https://doi.org/10.1089/105072503770867192CrossRefPubMed

47.

M.E. Romano, G.M. Webster, A.M. Vuong, R.T. Zoeller, A. Chen, A.N. Hoofnagle, A.M. Calafat, M.R. Karagas, K. Yolton, B.P. Lanphear, J.M. Braun, Gestational urinary bisphenol A and maternal and newborn thyroid hormone concentrations: The HOME Study. Environ. Res. 138, 453–460 (2015). https://doi.org/10.1016/J.ENVRES.2015.03.003CrossRefPubMedPubMedCentral

48.

J. Chevrier, R.B. Gunier, A. Bradman, N.T. Holland, A.M. Calafat, B. Eskenazi, K.G. Harley, Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ. Health Perspect. 121, 138–144 (2013). https://doi.org/10.1289/ehp.1205092CrossRefPubMed

49.

L.A. Meserve, B.A. Murray, J.A. Landis, Influence of maternal ingestion of Aroclor 1254® (PCB) or Firemaster BP-6® (PBB) on unstimulated and stimulated corticosterone levels in young rats. Bull. Environ. Contamination Toxicol., 48, (1992). https://doi.org/10.1007/BF00195992.

50.

M.P. Reilly, C.D. Weeks, V.Y. Topper, L.M. Thompson, D. Crews, A.C. Gore, The effects of prenatal PCBs on adult social behavior in rats. Hormones Behav. 73, 47–55 (2015). https://doi.org/10.1016/j.yhbeh.2015.06.002CrossRef

51.

R. Salgado-Freiría, S. López-Doval, A. Lafuente, Perfluorooctane sulfonate (PFOS) can alter the hypothalamic–pituitary–adrenal (HPA) axis activity by modifying CRF1 and glucocorticoid receptors. Toxicol. Lett. 295, 1–9 (2018). https://doi.org/10.1016/J.TOXLET.2018.05.025CrossRefPubMed

52.

F. Chen, L. Zhou, Y. Bai, R. Zhou, L. Chen, Sex differences in the adult HPA axis and affective behaviors are altered by perinatal exposure to a low dose of bisphenol A. Brain Res. 1571, 12–24 (2014). https://doi.org/10.1016/j.brainres.2014.05.010CrossRefPubMed

53.

J.T. Wolstenholme, J.A. Taylor, S.R.J. Shetty, M. Edwards, J.J. Connelly, E.F. Rissman, Gestational exposure to low dose bisphenol A alters social behavior in juvenile mice. PLoS ONE 6, e25448 (2011). https://doi.org/10.1371/journal.pone.0025448CrossRefPubMedPubMedCentral

54.

A.W. Sullivan, E.C. Beach, L.A. Stetzik, A. Perry, A.S. D’Addezio, B.S. Cushing, H.B. Patisaul, A novel model for neuroendocrine toxicology: neurobehavioral effects of BPA exposure in a prosocial species, the Prairie Vole (Microtus ochrogaster). Endocrinology 155, 3867–3881 (2014). https://doi.org/10.1210/en.2014-1379CrossRefPubMedPubMedCentral

55.

M.P. Reilly, M.N. Kunkel, L.M. Thompson, A. Zentay, C.D. Weeks, D. Crews, L.K. Cormack, A.C. Gore, Effects of endocrine‐disrupting chemicals on hypothalamic oxytocin and vasopressin systems. J. Exp. Zool. Part. A: Ecol. Integr. Physiol. 337, 75–87 (2022). https://doi.org/10.1002/jez.2475CrossRef

56.

J.A. Goldsby, J.T. Wolstenholme, E.F. Rissman, Multi- and transgenerational consequences of bisphenol A on sexually dimorphic cell populations in mouse brain. Endocrinology 158, 21–30 (2017). https://doi.org/10.1210/en.2016-1188CrossRefPubMed

57.

A. Shah, C.G. Coburn, A. Watson-Siriboe, R. Whitley, A. Shahidzadeh, E.R. Gillard, R. Nichol, M. Leon-Olea, M. Gaertner, P.R.S. Kodavanti, M.C. Currás-Collazo, Altered cardiovascular reactivity and osmoregulation during hyperosmotic stress in adult rats developmentally exposed to polybrominated diphenyl ethers (PBDEs). Toxicol. Appl. Pharmacol. 256, 103–113 (2011). https://doi.org/10.1016/j.taap.2011.07.014CrossRefPubMed

58.

M.M. Grumbach, The neuroendocrinology of human puberty revisited. Horm. Res. Paediatrics 57, 2–14 (2002). https://doi.org/10.1159/000058094CrossRef

59.

A. Acevedo‐Rodriguez, A.S. Kauffman, B.D. Cherrington, C.S. Borges, T.A. Roepke, M. Laconi, Emerging insights into hypothalamic‐pituitary‐gonadal axis regulation and interaction with stress signalling. J. Neuroendocrinol. 30, (2018). https://doi.org/10.1111/jne.12590.

60.

T.A. Roepke, N.C. Sadlier, Reproductive Toxicology: Impact of endocrine disruptors on neurons expressing GnRH or kisspeptin and pituitary gonadotropins. Reproduction 162, F131–F145 (2021). https://doi.org/10.1530/REP-20-0612CrossRefPubMedPubMedCentral

61.

C. Wohlfahrt-Veje, H.R. Andersen, I.M. Schmidt, L. Aksglaede, K. Sørensen, A. Juul, T.K. Jensen, P. Grandjean, N.E. Skakkebaek, K.M. Main, Early breast development in girls after prenatal exposure to non-persistent pesticides. Int. J. Androl. 35, 273–282 (2012). https://doi.org/10.1111/j.1365-2605.2011.01244.xCrossRefPubMed

62.

K.J. Marks, T.J. Hartman, E.V. Taylor, M.E. Rybak, K. Northstone, M: Marcus, Exposure to phytoestrogens in utero and age at menarche in a contemporary British cohort. Environ. Res. 155, 287–293 (2017). https://doi.org/10.1016/j.envres.2017.02.030CrossRefPubMedPubMedCentral

63.

K.G. Harley, S.A. Rauch, J. Chevrier, K. Kogut, K.L. Parra, C. Trujillo, R.H. Lustig, L.C. Greenspan, A. Sjödin, A. Bradman, B. Eskenazi, Association of prenatal and childhood PBDE exposure with timing of puberty in boys and girls. Environ. Int. 100, 132–138 (2017). https://doi.org/10.1016/j.envint.2017.01.003CrossRefPubMedPubMedCentral

64.

G.C. Windham, S.M. Pinney, R.W. Voss, A. Sjödin, F.M. Biro, L.C. Greenspan, S. Stewart, R.A. Hiatt, L.H. Kushi, Brominated flame retardants and other persistent organohalogenated compounds in relation to timing of puberty in a longitudinal study of girls. Environ. Health Perspect. 123, 1046–1052 (2015). https://doi.org/10.1289/ehp.1408778CrossRefPubMedPubMedCentral

65.

D. Franssen, T. Svingen, D.L. Rodriguez, M. Duursen, J. van, Boberg, A.S. Parent, A putative adverse outcome pathway network for disrupted female pubertal onset to improve testing and regulation of endocrine disrupting chemicals. Neuroendocrinology 112, 101–114 (2022). https://doi.org/10.1159/000515478CrossRefPubMed

66.

D. Lopez-Rodriguez, R. Scientist, D. Franssen, I.B. Science, S. Heger, P. Endocrinologist, A.-S. Parent, Endocrine-disrupting chemicals and their effects on puberty. Best. Pract. Res.: Clin. Endocrinol. Metab. 35, 101579 (2021). https://doi.org/10.1016/J.BEEM.2021.101579CrossRef

67.

W. Xi, C.K.F. Lee, W.S.B. Yeung, J.P. Giesy, M.H. Wong, X. Zhang, M. Hecker, C.K.C. Wong, Effect of perinatal and postnatal bisphenol A exposure to the regulatory circuits at the hypothalamus–pituitary–gonadal axis of CD-1 mice. Reprod. Toxicol. 31, 409–417 (2011). https://doi.org/10.1016/j.reprotox.2010.12.002CrossRefPubMed

68.

Y. Bai, F. Chang, R. Zhou, P.-P. Jin, H. Matsumoto, M. Sokabe, L. Chen, Increase of anteroventral periventricular kisspeptin neurons and generation of E2-induced LH-surge system in male rats exposed perinatally to environmental dose of bisphenol-A. Endocrinology 152, 1562–1571 (2011). https://doi.org/10.1210/en.2010-1042CrossRefPubMed

69.

L. Naulé, M. Picot, M. Martini, C. Parmentier, H. Hardin-Pouzet, M. Keller, I. Franceschini, S. Mhaouty-Kodja, Neuroendocrine and behavioral effects of maternal exposure to oral bisphenol A in female mice. J. Endocrinol. 220, 375–388 (2014). https://doi.org/10.1530/JOE-13-0607CrossRefPubMed

70.

H.B. Patisaul, K.L. Todd, J.A. Mickens, H.B. Adewale, Impact of neonatal exposure to the ERα agonist PPT, bisphenol-A or phytoestrogens on hypothalamic kisspeptin fiber density in male and female rats. NeuroToxicology 30, 350–357 (2009). https://doi.org/10.1016/j.neuro.2009.02.010CrossRefPubMedPubMedCentral

71.

S.M. Losa-Ward, K.L. Todd, K.A. McCaffrey, K. Tsutsui, H.B. Patisaul, Disrupted Organization of RFamide Pathways in the Hypothalamus Is Associated with Advanced Puberty in Female Rats Neonatally Exposed to Bisphenol A1. Biol. Reprod. 87, (2012). https://doi.org/10.1095/biolreprod.112.100826.

72.

F. Ruiz-Pino, D. Miceli, D. Franssen, M.J. Vazquez, A. Farinetti, J.M. Castellano, G. Panzica, M. Tena-Sempere, Environmentally Relevant Perinatal Exposures to Bisphenol A Disrupt Postnatal Kiss1/NKB Neuronal Maturation and Puberty Onset in Female Mice. Environ. Health Perspect. 127, (2019). https://doi.org/10.1289/EHP5570.

73.

S.M. Dickerson, S.L. Cunningham, H.B. Patisaul, M.J. Woller, A.C. Gore, Endocrine disruption of brain sexual differentiation by developmental PCB exposure. Endocrinology 152, 581–594 (2011). https://doi.org/10.1210/en.2010-1103CrossRefPubMed

74.

M. Bellingham, P.A. Fowler, M.R. Amezaga, S.M. Rhind, C. Cotinot, B. Mandon-Pepin, R.M. Sharpe, N.P. Evans, Exposure to a complex cocktail of environmental endocrine-disrupting compounds disturbs the kisspeptin/GPR54 system in ovine hypothalamus and pituitary gland. Environ. Health Perspect. 117, 1556–1562 (2009). https://doi.org/10.1289/ehp.0900699CrossRefPubMedPubMedCentral

75.

S.M. Dickerson, S.L. Cunningham, A.C. Gore, Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus. Toxicol. Appl. Pharmacol. 252, 36–46 (2011). https://doi.org/10.1016/j.taap.2011.01.012CrossRefPubMedPubMedCentral

76.

D.M. Walker, B.A. Kermath, M.J. Woller, A.C. Gore, Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors. Endocrinology 154, 2129–2143 (2013). https://doi.org/10.1210/en.2012-2123CrossRefPubMedPubMedCentral

77.

J. Hu, G. Du, W. Zhang, H. Huang, D. Chen, D. Wu, X. Wang, Short-term neonatal/prepubertal exposure of dibutyl phthalate (DBP) advanced pubertal timing and affected hypothalamic kisspeptin/GPR54 expression differently in female rats. Toxicology 314, 65–75 (2013). https://doi.org/10.1016/j.tox.2013.09.007CrossRefPubMed

78.

J.A. Mohawk, C.B. Green, J.S. Takahashi, Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 35, 445–462 (2012). https://doi.org/10.1146/annurev-neuro-060909-153128CrossRefPubMedPubMedCentral

79.

A. Sehgal, Physiology flies with time. Cell 171, 1232–1235 (2017). https://doi.org/10.1016/j.cell.2017.11.028CrossRefPubMed

80.

A. Sen, M.T. Sellix, The circadian timing system and environmental circadian disruption: From follicles to fertility. Endocrinology 157, 3366–3373 (2016). https://doi.org/10.1210/en.2016-1450CrossRefPubMed

81.

K. Ikegami, S. Refetoff, Evan Cauter, T. Yoshimura, Interconnection between circadian clocks and thyroid function. Nat. Rev. Endocrinol. 15, 590–600 (2019). https://doi.org/10.1038/S41574-019-0237-ZCrossRefPubMedPubMedCentral

82.

N.M. Kettner, C.A. Katchy, L. Fu, Circadian gene variants in cancer. Ann. Med. 46, 208 (2014). https://doi.org/10.3109/07853890.2014.914808CrossRefPubMed

83.

S.-H. Yoo, S. Yamazaki, P.L. Lowrey, K. Shimomura, C.H. Ko, E.D. Buhr, S.M. Siepka, H.-K. Hong, W.J. Oh, O.J. Yoo, M. Menaker, J.S. Takahashi, PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl Acad. Sci. 101, 5339–5346 (2004). https://doi.org/10.1073/pnas.0308709101CrossRefPubMedPubMedCentral

84.

A.M. Neumann, C.X. Schmidt, R.M. Brockmann, H. Oster, Circadian regulation of endocrine systems. Autonomic Neurosci.: Basic. Clin. 216, 1–8 (2019). https://doi.org/10.1016/j.autneu.2018.10.001CrossRef

85.

G.M. Leclerc, F.R. Boockfor, Pulses of prolactin promoter activity depend on a noncanonical E-box that can bind the circadian proteins CLOCK and BMAL1. Endocrinology 146, 2782–2790 (2005). https://doi.org/10.1210/en.2005-0100CrossRefPubMed

86.

S.A. Patel, A. Chaudhari, R. Gupta, N. Velingkaar, R.V. Kondratov, Circadian clocks govern calorie restriction—mediated life span extension through BMAL1‐ and IGF‐1‐dependent mechanisms. FASEB J. 30, 1634–1642 (2016). https://doi.org/10.1096/fj.15-282475CrossRefPubMed

87.

V. Jiménez-Ortega, P.C. Barquilla, P. Fernández-Mateos, D.P. Cardinali, A.I. Esquifino, Cadmium as an endocrine disruptor: correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin. Free. Radic. Biol. Med. 53, 2287–2297 (2012). https://doi.org/10.1016/J.FREERADBIOMED.2012.10.533CrossRefPubMed

88.

N. Loganathan, A. Salehi, J.A. Chalmers, D.D. Belsham, Bisphenol A alters Bmal1, Per2, and Rev-Erba mRNA and requires Bmal1 to increase neuropeptide Y expression in hypothalamic neurons. Endocrinology 160, 181–192 (2019). https://doi.org/10.1210/en.2018-00881CrossRefPubMed

89.

M. Mukai, T.M. Lin, R.E. Peterson, P.S. Cooke, S.A. Tischkau, Behavioral rhythmicity of mice lacking AhR and attenuation of light-induced phase shift by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Rhythm. 23, 200–210 (2008). https://doi.org/10.1177/0748730408316022CrossRef

90.

R. Kopp, I.O. Martínez, J. Legradi, J. Legler, Exposure to endocrine disrupting chemicals perturbs lipid metabolism and circadian rhythms. J. Environ. Sci. 62, 133–137 (2017). https://doi.org/10.1016/j.jes.2017.10.013CrossRef

91.

D.M. Walker, B.M. Goetz, A.C. Gore, Dynamic postnatal developmental and sex-specific neuroendocrine effects of prenatal polychlorinated biphenyls in rats. Mol. Endocrinol. 28, 99–115 (2014). https://doi.org/10.1210/me.2013-1270CrossRefPubMed

92.

M.R. Bell, L.M. Thompson, K. Rodriguez, A.C. Gore, Two-hit exposure to polychlorinated biphenyls at gestational and juvenile life stages: 1. Sexually dimorphic effects on social and anxiety-like behaviors. Hormones Behav. 78, 168–177 (2016). https://doi.org/10.1016/j.yhbeh.2015.11.007CrossRef

93.

N. Kiliç, S. Sandal, N. Çolakoglu, S. Kutlu, A. Seyran, B. Yilmaz, Endocrine disruptive effects of polychlorinated biphenyls on the thyroid gland in female rats. Tohoku J. Exp. Med. 206, 327–332 (2005). https://doi.org/10.1620/tjem.206.327CrossRefPubMed

94.

L.E. Braverman, X. He, S. Pino, M. Cross, B. Magnani, S.H. Lamm, M.B. Kruse, A. Engel, K.S. Crump, J.P. Gibbs, The effect of perchlorate, thiocyanate, and nitrate on thyroid function in workers exposed to perchlorate long-term. J. Clin. Endocrinol. Metab. 90, 700–706 (2005). https://doi.org/10.1210/jc.2004-1821CrossRefPubMed

95.

K.G. Harley, R.B. Gunier, K. Kogut, C. Johnson, A. Bradman, A.M. Calafat, B. Eskenazi, Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ. Res. 126, 43–50 (2013). https://doi.org/10.1016/j.envres.2013.06.004CrossRefPubMedPubMedCentral

96.

E.F. Fitzgerald, S. Shrestha, M.I. Gomez, R.J. McCaffrey, E.A. Zimmerman, K. Kannan, S. Hwang, Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and neuropsychological status among older adults in New York. NeuroToxicology 33, 8–15 (2012). https://doi.org/10.1016/j.neuro.2011.10.011CrossRefPubMed

97.

D. Levie, T.I.M. Korevaar, S.C. Bath, A. Dalmau-Bueno, M. Murcia, M. Espada, M. Dineva, J.M. Ibarluzea, J. Sunyer, H. Tiemeier, M. Rebagliato, M.P. Rayman, R.P. Peeters, M. Guxens, Thyroid function in early pregnancy, child IQ, and autistic traits: a meta-analysis of individual participant data. J. Clin. Endocrinol. Metab. 103, 2967–2979 (2018). https://doi.org/10.1210/jc.2018-00224CrossRefPubMed

98.

O. Boucher, G. Muckle, J.L. Jacobson, R.C. Carter, M. Kaplan-Estrin, P. Ayotte, É. Dewailly, S.W. Jacobson, Domain-specific effects of prenatal exposure to PCBs, mercury, and lead on infant cognition: results from the environmental contaminants and child development study in Nunavik. Environ. Health Perspect. 122, 310–316 (2014). https://doi.org/10.1289/ehp.1206323CrossRefPubMedPubMedCentral

99.

Y. Kim, E. Ha, E. Kim, H. Park, M. Ha, J. Kim, Y. Hong, N. Chang, B. Kim, Prenatal exposure to phthalates and infant development at 6 months: prospective mothers and children’s environmental health (MOCEH) study. Environ. Health Perspect. 119, 1495–1500 (2011). https://doi.org/10.1289/ehp.1003178CrossRefPubMedPubMedCentral

100.

A. Chen, K. Yolton, S.A. Rauch, G.M. Webster, R. Hornung, A. Sjödin, K.N. Dietrich, B.P. Lanphear, Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U.S. children through 5 years of age: the HOME study. Environ. Health Perspect. 122, 856–862 (2014). https://doi.org/10.1289/ehp.1307562CrossRefPubMedPubMedCentral

101.

N. el Majidi, M. Bouchard, G. Carrier, Systematic analysis of the relationship between standardized biological levels of polychlorinated biphenyls and thyroid function in pregnant women and newborns. Chemosphere 98, 1–17 (2014). https://doi.org/10.1016/j.chemosphere.2013.10.006CrossRefPubMed

102.

International Agency for Research on Cancer Classifications. Available at https://monographs.iarc.who.int/agents-classified-by-the-iarc/. [Accessed April 7, 2022].

103.

P.W. Stewart, E. Lonky, J. Reihman, J. Pagano, B.B. Gump, T. Darvill, The relationship between prenatal PCB exposure and intelligence (IQ) in 9-year-old children. Environ. Health Perspect. 116, 1416–1422 (2008). https://doi.org/10.1289/ehp.11058CrossRefPubMedPubMedCentral

104.

M.S. Bloom, J.E. Vena, J.R. Olson, P.J. Kostyniak, Assessment of polychlorinated biphenyl congeners, thyroid stimulating hormone, and free thyroxine among New York State anglers. Int. J. Hyg. Environ. Health 212, 599–611 (2009). https://doi.org/10.1016/j.ijheh.2009.04.005CrossRefPubMed

105.

W. Miyazaki, T. Iwasaki, A. Takeshita, C. Tohyama, N. Koibuchi, Identification of the functional domain of thyroid hormone receptor responsible for polychlorinated biphenyl–mediated suppression of its action in vitro. Environ. Health Perspect. 116, 1231–1236 (2008). https://doi.org/10.1289/ehp.11176CrossRefPubMedPubMedCentral

106.

K.J. Gauger, S. Giera, D.S. Sharlin, R. Bansal, E. Iannacone, R.T. Zoeller, Polychlorinated biphenyls 105 and 118 form thyroid hormone receptor agonists after cytochrome P4501A1 activation in rat pituitary GH3 cells. Environ. Health Perspect. 115, 1623–1630 (2007). https://doi.org/10.1289/ehp.10328CrossRefPubMedPubMedCentral

107.

J.B. Herbstman, A. Sjödin, M. Kurzon, S.A. Lederman, R.S. Jones, V. Rauh, L.L. Needham, D. Tang, M. Niedzwiecki, R.Y. Wang, F. Perera, Prenatal exposure to PBDEs and neurodevelopment. Environ. Health Perspect. 118, 712–719 (2010). https://doi.org/10.1289/ehp.0901340CrossRefPubMedPubMedCentral

108.

A. Julander, M. Karlsson, K. Hagström, C.G. Ohlson, M. Engwall, I.-L. Bryngelsson, H. Westberg, B. van Bavel, Polybrominated diphenyl ethers—plasma levels and thyroid status of workers at an electronic recycling facility. Int. Arch. Occup. Environ. Health 78, 584–592 (2005). https://doi.org/10.1007/s00420-005-0627-5CrossRefPubMed

109.

M.E. Turyk, V.W. Persky, P. Imm, L. Knobeloch, R. Chatterton, H.A. Anderson, Hormone disruption by PBDEs in adult male sport fish consumers. Environ. Health Perspect. 116, 1635–1641 (2008). https://doi.org/10.1289/ehp.11707CrossRefPubMedPubMedCentral

110.

E. Gaitan, R.C. Cooksey, D. Matthews, R. Presson, In vitro measurement of antithyroid compounds and environmental Goitrogens. J. Clin. Endocrinol. Metab. 56, 767–773 (1983). https://doi.org/10.1210/jcem-56-4-767CrossRefPubMed

111.

J.D. Meeker, K.K. Ferguson, Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the national health and nutrition examination survey (NHANES) 2007–2008. Environ. Health Perspect. 119, 1396–1402 (2011). https://doi.org/10.1289/ehp.1103582CrossRefPubMedPubMedCentral

112.

C. Park, W. Choi, M. Hwang, Y. Lee, S. Kim, S. Yu, I. Lee, D. Paek, K. Choi, Associations between urinary phthalate metabolites and bisphenol A levels, and serum thyroid hormones among the Korean adult population - Korean National Environmental Health Survey (KoNEHS) 2012–2014. Sci. Total. Environ. 584–585, 950–957 (2017). https://doi.org/10.1016/j.scitotenv.2017.01.144CrossRefPubMed

113.

C. Sriphrapradang, L. Chailurkit, W. Aekplakorn, B. Ongphiphadhanakul, Association between bisphenol A and abnormal free thyroxine level in men. Endocrine 44, 441–447 (2013). https://doi.org/10.1007/s12020-013-9889-yCrossRefPubMed

114.

T. Wang, J. Lu, M. Xu, Y. Xu, M. Li, Y. Liu, X. Tian, Y. Chen, M. Dai, W. Wang, S. Lai, Y. Bi, G. Ning, Urinary Bisphenol A Concentration and Thyroid Function in Chinese Adults. Epidemiology 24, 295–302 (2013). https://doi.org/10.1097/EDE.0b013e318280e02fCrossRefPubMed

115.

G.R. Marchesini, A. Meimaridou, W. Haasnoot, E. Meulenberg, F. Albertus, M. Mizuguchi, M. Takeuchi, H. Irth, A.J. Murk, Biosensor discovery of thyroxine transport disrupting chemicals. Toxicol. Appl. Pharmacol. 232, 150–160 (2008). https://doi.org/10.1016/j.taap.2008.06.014CrossRefPubMed

116.

M.L. Jugan, M. Lévy-Bimbot, M. Pomérance, S. Tamisier-Karolak, J.P. Blondeau, Y. Lévi, A new bioluminescent cellular assay to measure the transcriptional effects of chemicals that modulate the alpha-1 thyroid hormone receptor. Toxicol. Vitr. 21, 1197–1205 (2007). https://doi.org/10.1016/j.tiv.2007.03.020CrossRef

117.

M.M. da Silva, C.F.L. Gonçalves, L. Miranda-Alves, R.S. Fortunato, D.P. Carvalho, A.C.F. Ferreira, Inhibition of type 1 iodothyronine deiodinase by bisphenol A. Horm. Metab. Res. 51, 671–677 (2019). https://doi.org/10.1055/a-0919-3879CrossRefPubMed

118.

S. Lee, C. Kim, H. Shin, Y. Kho, K. Choi, Comparison of thyroid hormone disruption potentials by bisphenols A, S, F, and Z in embryo-larval zebrafish. Chemosphere 221, 115–123 (2019). https://doi.org/10.1016/j.chemosphere.2019.01.019CrossRefPubMed

119.

D. Cuomo, I. Porreca, G. Cobellis, R. Tarallo, G. Nassa, G. Falco, A. Nardone, F. Rizzo, M. Mallardo, C. Ambrosino, Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands. Mol. Cell. Endocrinol. 457, 20–34 (2017). https://doi.org/10.1016/j.mce.2017.01.027CrossRefPubMed

120.

D. Gentilcore, I. Porreca, F. Rizzo, E. Ganbaatar, E. Carchia, M. Mallardo, M. de Felice, C. Ambrosino, Bisphenol A interferes with thyroid specific gene expression. Toxicology 304, 21–31 (2013). https://doi.org/10.1016/j.tox.2012.12.001CrossRefPubMed

121.

S. Iwamuro, M. Yamada, M. Kato, S. Kikuyama, Effects of bisphenol A on thyroid hormone-dependent up-regulation of thyroid hormone receptor α and β and down-regulation of retinoid X receptor γ in Xenopus tail culture. Life Sci. 79, 2165–2171 (2006). https://doi.org/10.1016/j.lfs.2006.07.013CrossRefPubMed

122.

S. Sugiyama, N. Shimada, H. Miyoshi, K. Yamauchi, Detection of thyroid system–disrupting chemicals using in vitro and in vivo screening assays in Xenopus laevis. Toxicological Sci. 88, 367–374 (2005). https://doi.org/10.1093/toxsci/kfi330CrossRef

123.

A.I. Castillo, R. Sánchez-Martínez, J.L. Moreno, O.A. Martínez-Iglesias, D. Palacios, A. Aranda, A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid. Mol. Cell. Biol. 24, 502–513 (2004). https://doi.org/10.1128/MCB.24.2.502-513.2004CrossRefPubMedPubMedCentral

124.

S. Kitamura, S. Shinohara, E. Iwase, K. Sugihara, N. Uramaru, H. Shigematsu, N. Fujimoto, S. Ohta, Affinity for thyroid hormone and estrogen receptors of hydroxylated polybrominated diphenyl ethers. J. Health Sci. 54, 607–614 (2008). https://doi.org/10.1248/jhs.54.607CrossRef

125.

S. Kitamura, T. Kato, M. Iida, N. Jinno, T. Suzuki, S. Ohta, N. Fujimoto, H. Hanada, K. Kashiwagi, A. Kashiwagi, Anti-thyroid hormonal activity of tetrabromobisphenol A, a flame retardant, and related compounds: Affinity to the mammalian thyroid hormone receptor, and effect on tadpole metamorphosis. Life Sci. 76, 1589–1601 (2005). https://doi.org/10.1016/j.lfs.2004.08.030CrossRefPubMed

126.

A.C. Bianco, D. Salvatore, B. Gereben, M.J. Berry, P.R. Larsen, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002). https://doi.org/10.1210/edrv.23.1.0455CrossRefPubMed

127.

K. Nanba, A.R. Blinder, W.E. Rainey, Primary cultures and cell lines for “in vitro” modeling of the human adrenal cortex. Tohoku J. Exp. Med. 253, 217–232 (2021). https://doi.org/10.1620/tjem.253.217CrossRefPubMed

128.

W. Ribelin, The effects of drugs and chemicals upon the structure of the adrenal gland. Fundamental Appl. Toxicol. 4, 105–119 (1984). https://doi.org/10.1016/0272-0590(84)90224-0CrossRef

129.

S. Szabo, I. Lippe, Th.: Adrenal gland: chemically induced structural and functional changes in the cortex. Toxicol. Pathol. 17, 317–329 (1989). https://doi.org/10.1177/019262338901700208CrossRefPubMed

130.

J.T. Sanderson, The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicological Sci. 94, 3–21 (2006). https://doi.org/10.1093/toxsci/kfl051CrossRef

131.

S.A. Whitehead, S. Rice, Endocrine-disrupting chemicals as modulators of sex steroid synthesis. Best. Pract. Res. Clin. Endocrinol. Metab. 20, 45–61 (2006). https://doi.org/10.1016/j.beem.2005.09.003CrossRefPubMed

132.

K.Svechnikov, G.Izzo, L.Landreh, J.Weisser, O.Söder,, Endocrine disruptors and leydig cell function. J. Biomed. Biotechnol 2010, 1–10 (2010). https://doi.org/10.1155/2010/684504CrossRef

133.

E.C. Bonefeld-Jørgensen, M. Long, M.V. Hofmeister, A.M. Vinggaard, Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4- n -nonylphenol, and 4- n -octylphenol in vitro: new data and a brief review. Environ. Health Perspect. 115, 69–76 (2007). https://doi.org/10.1289/ehp.9368CrossRefPubMedPubMedCentral

134.

J.P. Hinson, P.W. Raven, Adrenal toxicology. In Endocrine and Hormonal Toxicology, edited by K.C. Rush (Wiley, 1999), pp. 67–90.

135.

J. Guo, X. Yuan, L. Qiu, W. Zhu, C. Wang, G. Hu, Y. Chu, L. Ye, Y. Xu, R.-S. Ge, Inhibition of human and rat 11β-hydroxysteroid dehydrogenases activities by bisphenol A. Toxicol. Lett. 215, 126–130 (2012). https://doi.org/10.1016/j.toxlet.2012.10.002CrossRefPubMed

136.

R.H. Waring, S. Ayers, A.J. Gescher, H.-R. Glatt, W. Meinl, P. Jarratt, C.J. Kirk, T. Pettitt, D. Rea, R.M. Harris, Phytoestrogens and xenoestrogens: The contribution of diet and environment to endocrine disruption. J. Steroid Biochem. Mol. Biol. 108, 213–220 (2008). https://doi.org/10.1016/j.jsbmb.2007.09.007CrossRefPubMed

137.

R. Harris, R. Waring, Sulfotransferase inhibition: potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. Curr. Drug. Metab. 9, 269–275 (2008). https://doi.org/10.2174/138920008784220637CrossRefPubMed

138.

R. Prasad, J.C. Kowalczyk, E. Meimaridou, H.L. Storr, L.A. Metherell, Oxidative stress and adrenocortical insufficiency. J. Endocrinol. 221, R63–R73 (2014). https://doi.org/10.1530/JOE-13-0346CrossRefPubMedPubMedCentral

139.

R. Meli, A. Monnolo, C. Annunziata, C. Pirozzi, M.C. Ferrante, Oxidative stress and BPA toxicity: an antioxidant approach for male and female reproductive dysfunction. Antioxidants 9, 405 (2020). https://doi.org/10.3390/antiox9050405CrossRefPubMedCentral

140.

B.-O. Lund, Å. Bergman, I. Brandt, Metabolic activation and toxicity of a DDT-metabolite, 3-methylsulphonyl-DDE, in the adrenal Zona fasciculata in mice. Chem.-Biol. Interact. 65, 25–40 (1988). https://doi.org/10.1016/0009-2797(88)90028-2CrossRefPubMed

141.

A. Ahmed, Comparative disposition of acrylonitrile and methacrylonitrile: quantitative whole-body autoradiographic studies in rats. Fundamental Appl. Toxicol. 33, 49–59 (1996). https://doi.org/10.1006/faat.1996.0142CrossRef

142.

I. Brandt, Å. Bergman, PCB methyl sulphones and related compounds: identification of target cells and tissues in different species. Chemosphere 16, 1671–1676 (1987). https://doi.org/10.1016/0045-6535(87)90147-0CrossRef

143.

W. Brogan, Effects of carbon tetrachloride on adrenocortical structure and function in guinea pigs. Toxicol. Appl. Pharmacol. 75, 118–127 (1984). https://doi.org/10.1016/0041-008X(84)90082-6CrossRefPubMed

144.

G. Vinson, J. Hinson, Blood flow and hormone secretion in the adrenal gland. In The Adrenal Gland, edited by V. James (Raven Press, 1992), pp. 71–86.

145.

J.P. Hinson, P.W. Raven, Effects of endocrine-disrupting chemicals on adrenal function. Best. Pract. Res. Clin. Endocrinol. Metab. 20, 111–120 (2006). https://doi.org/10.1016/j.beem.2005.09.006CrossRefPubMed

146.

K. Alejo-González, E. Hanson-Viana, R. Vazquez-Duhalt, Enzymatic detoxification of organophosphorus pesticides and related toxicants. J. Pestic. Sci. 43, 1–9 (2018). https://doi.org/10.1584/jpestics.D17-078CrossRefPubMedPubMedCentral

147.

A.O. Docea, L. Vassilopoulou, D. Fragou, A.L. Arsene, C. Fenga, L. Kovatsi, D. Petrakis, V.N. Rakitskii, A.E. Nosyrev, B.N. Izotov, K.S. Golokhvast, A.M. Zakharenko, A. Vakis, C. Tsitsimpikou, N. Drakoulis, CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol. Rep. 4, 335–341 (2017). https://doi.org/10.1016/j.toxrep.2017.05.007CrossRefPubMedPubMedCentral

148.

H. Yamazaki, T. Shimada, M.V. Martin, F.P. Guengerich, Stimulation of cytochrome P450 reactions by Apo-cytochromeb 5. J. Biol. Chem. 276, 30885–30891 (2001). https://doi.org/10.1074/jbc.M105011200CrossRefPubMed

149.

N.V. Yaglova, E.P. Timokhina, V.V. Yaglov, S.S. Obernikhin, S.V. Nazimova, D.A. Tsomartova, Changes in histophysiology of the adrenal medulla in rats after prenatal and postnatal exposure to endocrine disruptor DDT. Bull. Exp. Biol. Med. 169, 398–400 (2020). https://doi.org/10.1007/s10517-020-04895-6CrossRefPubMed

150.

E.P. Timokhina, S.V. Nazimova, D.A. Tsomartova, N.V. Yaglova, S.S. Obernikhin, V.V. Yaglov, Morphological and cytophysiological changes in the adult rat adrenal medulla after prenatal and postnatal exposure to endocrine-disrupting DDT. Sovremennye Tehnologii v. Med. 12, 50 (2020). https://doi.org/10.17691/stm2020.12.2.06CrossRef

151.

R.M. Sargis, Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals. Endocr. Disruptors 3, e1080788 (2015). https://doi.org/10.1080/23273747.2015.1080788CrossRef

152.

E. Fommei, R. Turci, A. Ripoli, S. Balzan, F. Bianchi, L. Morelli, A. Coi, Evidence for persistent organochlorine pollutants in the human adrenal cortex. J. Appl. Toxicol. 37, 1091–1097 (2017). https://doi.org/10.1002/jat.3460CrossRefPubMed

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands

Abstract

Background

Aims

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Aims

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2022

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question

Hypothalamic insulin expression remains unaltered after short-term fasting in female rats

Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery

Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes